480-91-1 | 2,3-Dihydroisoindol-1-one

Packsize	Purity	Availability	Price	Discounted Price
1g	97%	in stock	$8.00	$5.00
5g	97%	in stock	$19.00	$13.00
25g	97%	in stock	$78.00	$54.00
100g	97%	in stock	$198.00	$138.00

Description

• Catalog Number: AB46314
• Chemical Name: 2,3-Dihydroisoindol-1-one
• CAS Number: 480-91-1
• Molecular Formula: C8H7NO
• Molecular Weight: 133.1473
• MDL Number: MFCD03085939
• SMILES: O=C1NCc2c1cccc2
• NSC Number: 3689

Computed Properties

• Complexity: 155
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 10
• Hydrogen Bond Acceptor Count: 1
• Hydrogen Bond Donor Count: 1
• XLogP3: 0.8

Upstream Synthesis Route

2,3-Dihydro-1H-isoindol-1-one, also known as phthalimidine, is a versatile compound widely used in chemical synthesis. This bicyclic intermediate plays a crucial role in the production of various pharmaceuticals, agrochemicals, and specialty chemicals.In chemical synthesis, 2,3-Dihydro-1H-isoindol-1-one serves as a key building block for the synthesis of heterocyclic compounds. It can undergo reactions such as nucleophilic substitution, alkylation, and condensation to yield structurally diverse molecules. Its unique chemical properties make it valuable in the creation of analogs and derivatives with improved biological activities or physical properties.One common application of 2,3-Dihydro-1H-isoindol-1-one is in the synthesis of pharmaceutical drugs, where it serves as a core intermediate for the production of various medicines. Additionally, its utility extends to the synthesis of specialty chemicals used in industries such as cosmetics and materials science.Overall, 2,3-Dihydro-1H-isoindol-1-one plays a pivotal role in chemical synthesis, enabling the efficient and precise construction of complex molecules with diverse applications.

Literature

• 3-Oxoisoindoline-1-carboxamides: potent, state-dependent blockers of voltage-gated sodium channel Na(V)1.7 with efficacy in rat pain models.

  Journal of medicinal chemistry 20120809

• Rhodium-catalyzed synthesis of branched amines by direct addition of benzamides to imines.

  Organic letters 20120504

• (E)-Methyl 3-(3,4-dimeth-oxy-phen-yl)-2-[(1,3-dioxoisoindolin-2-yl)meth-yl]acrylate.

  Acta crystallographica. Section E, Structure reports online 20120401

• Rh(I)-catalyzed asymmetric synthesis of 3-substituted isoindolinones through CO gas-free aminocarbonylation.

  The Journal of organic chemistry 20120316

• Pharmacokinetics, metabolism and excretion of [(14)C]-lenalidomide following oral administration in healthy male subjects.

  Cancer chemotherapy and pharmacology 20120301

• Synthesis of extended, π-conjugated isoindolin-1-ones.

  The Journal of organic chemistry 20120203

• Daldinan A, a novel isoindolinone antioxidant from the ascomycete Daldinia concentrica.

  The Journal of antibiotics 20120201

• Clitocybin A, a novel isoindolinone, from the mushroom Clitocybe aurantiaca, inhibits cell proliferation through G1 phase arrest by regulating the PI3K/Akt cascade in vascular smooth muscle cells.

  Journal of pharmacological sciences 20120101

• Synthesis of a library of tricyclic azepinoisoindolinones.

  Beilstein journal of organic chemistry 20120101

• New heteroannulation reactions of N-alkoxybenzamides by Pd(II) catalyzed C-H activation.

  Organic letters 20111007

• MDM2-p53 protein-protein interaction inhibitors: a-ring substituted isoindolinones.

  Bioorganic & medicinal chemistry letters 20111001

• Assembly of the isoindolinone core of muironolide A by asymmetric intramolecular Diels-Alder cycloaddition.

  Organic letters 20110805

• Nickel(0)-catalyzed cyclization of N-benzoylaminals for isoindolinone synthesis.

  Organic letters 20110701

• Design, synthesis and biological assessment of novel N-substituted 3-(phthalimidin-2-yl)-2,6-dioxopiperidines and 3-substituted 2,6-dioxopiperidines for TNF-α inhibitory activity.

  Bioorganic & medicinal chemistry 20110701

• Understanding small-molecule binding to MDM2: insights into structural effects of isoindolinone inhibitors from NMR spectroscopy.

  Chemical biology & drug design 20110501

• The identification of synthetic organic pigments in modern paints and modern paintings using pyrolysis-gas chromatography-mass spectrometry.

  Analytical and bioanalytical chemistry 20110501

• Isoindolinone inhibitors of the murine double minute 2 (MDM2)-p53 protein-protein interaction: structure-activity studies leading to improved potency.

  Journal of medicinal chemistry 20110310

• 10-Hydr-oxy-2-aza-penta-cyclo-[10.8.0.0.0.0]icosa-1(12),4(9),5,7,13,15(20),16,18-octa-ene-3,11-dione.

  Acta crystallographica. Section E, Structure reports online 20110301

• Synthesis and blocking activities of isoindolinone- and isobenzofuranone-containing phenoxylalkylamines as potent α(1)-adrenoceptor antagonists.

  Chemical & pharmaceutical bulletin 20110101

• Central and Peripheral GABA(A) Receptor Regulation of the Heart Rate Depends on the Conscious State of the Animal.

  Advances in pharmacological sciences 20110101

• Drug discovery opportunities and challenges at g protein coupled receptors for long chain free Fatty acids.

  Frontiers in endocrinology 20110101

• Synthesis and nootropic activity of some 2,3-dihydro-1H-isoindol-1-one derivatives structurally related with piracetam.

  Chemistry & biodiversity 20101101

• Design, synthesis, and preliminary biological evaluation of pyrrolo[3,4-c]quinolin-1-one and oxoisoindoline derivatives as aggrecanase inhibitors.

  ChemMedChem 20100503

• Inadvertent polychlorinated biphenyls in commercial paint pigments.

  Environmental science & technology 20100415

• 2-(4-Hydroxy-biphenyl-3-yl)isoindolin-1-one.

  Acta crystallographica. Section E, Structure reports online 20100201

• Cardiovascular responses to intravenous injection of a novel isoindolin-1-one derivate in conscious rats.

  Brain research 20091201

• Clitocybins, novel isoindolinone free radical scavengers, from mushroom Clitocybe aurantiaca inhibit apoptotic cell death and cellular senescence.

  Biological & pharmaceutical bulletin 20091001

• Lenalidomide, an antineoplastic drug, and its hemihydrate.

  Acta crystallographica. Section C, Crystal structure communications 20091001

• 3-Eth-oxy-2-(1,3-thia-zol-2-yl)isoindolin-1-one.

  Acta crystallographica. Section E, Structure reports online 20091001

• Discovery and biological profile of isoindolinone derivatives as novel metabotropic glutamate receptor 1 antagonists: a potential treatment for psychotic disorders.

  Bioorganic & medicinal chemistry letters 20090915

• Analysis of chemical shift changes reveals the binding modes of isoindolinone inhibitors of the MDM2-p53 interaction.

  Journal of the American Chemical Society 20081126

• Syntheses of substituted 3-methyleneisoindolin-1-ones by a palladium-catalyzed Sonogashira coupling-carbonylation-hydroamination sequence in phosphonium salt-based ionic liquids.

  Organic letters 20081120

• Antinociceptive property of intrathecal and intraperitoneal administration of a novel water-soluble isoindolin-1-one derivative, JM 1232 (-) in rats.

  European journal of pharmacology 20081031

• Total synthesis of aristolactams via a one-pot suzuki-miyaura coupling/aldol condensation cascade reaction.

  Organic letters 20080821

• Sterenin A, B, C and D, novel 11beta-hydroxysteroid dehydrogenase type 1 inhibitors from Stereum sp. SANK 21205.

  The Journal of antibiotics 20080301

• Raman identification of yellow synthetic organic pigments in modern and contemporary paintings: reference spectra and case studies.

  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20080201

• Novel water-soluble sedative-hypnotic agents: isoindolin-1-one derivatives.

  Chemical & pharmaceutical bulletin 20071201

• A concise first total synthesis of narceine imide.

  Organic & biomolecular chemistry 20070507

• Small-molecule inhibitors of the MDM2-p53 protein-protein interaction based on an isoindolinone scaffold.

  Journal of medicinal chemistry 20061019

• RAF modulators and methods of use.

  Expert opinion on therapeutic patents 20060701

• Comparative study on the use of ortho-phthalaldehyde, naphthalene-2,3-dicarboxaldehyde and anthracene-2,3-dicarboxaldehyde reagents for alpha-amino acids followed by the enantiomer separation of the formed isoindolin-1-one derivatives using quinine-type chiral stationary phases.

  Journal of chromatography. A 20050812

• Synthesis of 4-(1-oxo-isoindoline) and 4-(5,6-dimethoxy-1-oxo-isoindoline)-substituted phenoxypropanolamines and their beta1-, beta2-adrenergic receptor binding studies.

  Bioorganic chemistry 20050801

• Isoindolinone ureas: a novel class of KDR kinase inhibitors.

  Bioorganic & medicinal chemistry letters 20040906

• Poly(ADP-ribose) polymerase contributes to the development of myocardial infarction in diabetic rats and regulates the nuclear translocation of apoptosis-inducing factor.

  The Journal of pharmacology and experimental therapeutics 20040801

• Synthesis and duplex DNA recognition studies of oligonucleotides containing a ureido isoindolin-1-one homo-N-nucleoside. A comparison of host-guest and DNA recognition studies.

  Bioorganic & medicinal chemistry 20040315

• The discovery and synthesis of novel adenosine substituted 2,3-dihydro-1H-isoindol-1-ones: potent inhibitors of poly(ADP-ribose) polymerase-1 (PARP-1).

  Bioorganic & medicinal chemistry letters 20040105

• Synthesis and SAR studies for the inhibition of TNF-alpha production. Part 2. 2-[3-(Cyclopentyloxy)-4-methoxyphenyl]-substituted-1-isoindolinone derivatives.

  Archives of pharmacal research 20020401

• cis-6-Phenyl-4bH,6H,11H,13H-isoindolo[1,2-c]benz[2,4]oxazepin-13-one.

  Acta crystallographica. Section C, Crystal structure communications 20010601